Joshua D. Schiffman,
MD
Languages Spoken: English
Labs: Website
Dr. Schiffman received his medical degree from Brown University School of Medicine, completed his Pediatric Residency, Pediatric Chief Residency, and Pediatric Hematology/Oncology Fellowship at Stanford University. He has been an investigator at the Huntsman Cancer Institute since 2008, and a faculty member at the University of Utah since 2009. Dr. Schiffman is board-certified in Pediatrics and Pediatric Hematology-Oncology.
He is currently a Professor of Pediatrics at the University of Utah, an Adjunct Professor in the Department of Oncological Sciences, and is in the Division of Hematology/Oncology at Primary Children´s Medical Center. He serves as the Medical Director of the High Risk Pediatric Cancer Clinic at Huntsman Cancer Institute where he cares for children and families with inherited risk for cancer. His specific clinical interests are cancer susceptibility in families, with a focus on the genomic changes necessary for cancer development.
Dr. Schiffman’s work in the High Risk Pediatric Cancer Clinic contributed to a landmark study in the field of clinical cancer genetics demonstrating that early cancer surveillance in families with Li-Fraumeni Syndrome significantly improves overall survival. He continues to work with children and families at high risk for cancer development to discover genes that may be targeted for both prevention and treatment of childhood cancer. Dr. Schiffman is also the Education Director for the Program in Personalized Health Care at the University of Utah, where he oversees the teaching of personalized medicine to physicians and their patients.
Clinical Locations
801-585-0100
Primary Children's Hospital
Pediatric Hematology/Oncology801-662-4700
Specialties
Board Certification and Academic Information
| Academic Departments | Pediatrics
-
Professor Oncological Sciences - Adjunct Professor |
| Academic Divisions | Pediatric Hematology/Oncology |
| Board Certification | American Board of Pediatrics (Sub: Pediatric Hematology-Oncology) American Board of Pediatrics (Pediatrics) |
| Cancer Center Programs | Nuclear Control of Cell Growth & Differentiation |
Dr. Schiffman received his medical degree from Brown University School of Medicine, completed his Pediatric Residency, Pediatric Chief Residency, and Pediatric Hematology/Oncology Fellowship at Stanford University. He has been an investigator at the Huntsman Cancer Institute since 2008, and a faculty member at the University of Utah since 2009. Dr. Schiffman is board-certified in Pediatrics and Pediatric Hematology-Oncology.
He is currently a Professor of Pediatrics at the University of Utah, an Adjunct Professor in the Department of Oncological Sciences, and is in the Division of Hematology/Oncology at Primary Children´s Medical Center. He serves as the Medical Director of the High Risk Pediatric Cancer Clinic at Huntsman Cancer Institute where he cares for children and families with inherited risk for cancer. His specific clinical interests are cancer susceptibility in families, with a focus on the genomic changes necessary for cancer development.
Dr. Schiffman’s work in the High Risk Pediatric Cancer Clinic contributed to a landmark study in the field of clinical cancer genetics demonstrating that early cancer surveillance in families with Li-Fraumeni Syndrome significantly improves overall survival. He continues to work with children and families at high risk for cancer development to discover genes that may be targeted for both prevention and treatment of childhood cancer. Dr. Schiffman is also the Education Director for the Program in Personalized Health Care at the University of Utah, where he oversees the teaching of personalized medicine to physicians and their patients.
Academic Locations
Huntsman Cancer Institute
801-587-4745
Board Certification and Academic Information
| Academic Departments | Pediatrics
-
Professor Oncological Sciences - Adjunct Professor |
| Academic Divisions | Pediatric Hematology/Oncology |
| Board Certification | American Board of Pediatrics (Sub: Pediatric Hematology-Oncology) American Board of Pediatrics (Pediatrics) |
| Cancer Center Programs | Nuclear Control of Cell Growth & Differentiation |
Research Interests
- Cancer Genetics
- Familial Cancer Susceptibility
- Li-Fraumeni Syndrome
- TP53 Mutation
- Ewing's Sarcoma
- Sarcoma
- Leukemia
- Paraganglioma
Education History
| Graduate Training | University of Utah Clinical Investigation [Genetics] M.Sc. |
| Fellowship | Stanford University Medical Center Pediatric Hematology/Oncology Fellow |
| Residency | Stanford University Medical Center Chief Medical Resident Resident |
| Residency | Stanford University Medical Center Pediatrics Resident |
| Internship | Stanford University School of Medicine Pediatrics Intern |
| Professional Medical | Brown University School of Medicine Medicine M.D. |
| Undergraduate | Brown University Psychology/Biology B.S. |
Selected Publications - Journal Articles
Journal Article
- Lupo PJ, Schraw JM, Desrosiers TA, Nembhard WN, Langlois PH, Canfield MA, Copeland G, Meyer RE, Brown AL, Chambers TM, Sok P, Danysh HE, Carozza SE, Sisoudiya SD, Hilsenbeck SG, Janitz AE, Oster ME, Scheuerle AE, Schiffman JD, Luo C, Mian A, Mueller BA, Huff CD, Rasmussen SA, Scheurer ME, Plon SE (2019). Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births. (Epub ahead of print) JAMA Oncol.
- Mowery DL, Kawamoto K, Bradshaw R, Kohlmann W, Schiffman JD, Weir C, Borbolla D, Chapman WW, Del Fiol G (2019). Determining Onset for Familial Breast and Colorectal Cancer from Family History Comments in the Electronic Health Record. AMIA Jt Summits Transl Sci Proc, 2019, 173-181.
- Tak CR, Biltaji E, Kohlmann W, Maese L, Hainaut P, Villani A, Malkin D, Sherwin CMT, Brixner DI, Schiffman JD (2019). Cost-effectiveness of early cancer surveillance for patients with Li-Fraumeni syndrome. Pediatr Blood Cancer, 66(5), e27629.
- Meyer JA, Zhou D, Mason CC, Downie JM, Rodic V, Abromowitch M, Wistinghausen B, Termuhlen AM, Angiolillo AL, Perkins SL, Lones MA, Barnette P, Schiffman JD, Miles RR (2016). Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues. Pediatr Blood Cancer, 64(7).
- Welch BM, OConnell NS, Qanungo S, Halbert-Hughes C, Schiffman JD (2015). Collecting Family Health History using an Online Social Network: a Nationwide Survey among Potential Users. AMIA Annu Symp Proc, 2015, 1316-25.
- Jones KB, Schiffman JD, Kohlmann W, Randall RL, Lessnick SL, Cannon-Albright LA (2011). Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes. Cancer Epidemiol Biomarkers Prev, 20(5), 751-7.
- Meeker ND, Yang JJ, Schiffman JD (2010). Pharmacogenomics of pediatric acute lymphoblastic leukemia. Expert Opin Pharmacother, 11(10), 1621-32.